Chemicals · Founded 2013 · www.aether.co.in · BSE 543534 · NSE AETHER · ISIN INE0BWX01014
No Notes Added Yet
Business
Aether Industries Ltd. is an Indian specialty chemical manufacturer focusing on advanced intermediates and specialty chemicals. The company operates an R&D-driven business model, specializing in complex and differentiated chemistry. It manufactures a diversified portfolio of products, serving various end-user industries globally, including Pharmaceuticals, Agrochemicals, Material Science, Coatings, and other fine and specialty chemicals. Aether makes money by selling these value-added specialty chemicals, primarily through two business models: large-scale manufacturing (LSM) of its own developed products and contract research and manufacturing services (CRAMS) for global clients.
Revenue Mix
Aether Industries does not typically provide a strict segment breakdown by business model (LSM vs. CRAMS) or product type with exact percentages in public domain consistently. However, their revenue is derived from:
Large Scale Manufacturing (LSM): Production of their own proprietary products, which constitutes the majority of revenue. These products are often advanced intermediates or specialty chemicals used across diverse industries.
Contract Research and Manufacturing Services (CRAMS): Custom synthesis and manufacturing for specific clients, often involving complex and exclusive chemistry projects.
While specific proportions can vary, LSM products generally contribute a larger share of the total revenue. Their products find applications across several industries, with Pharmaceuticals, Agrochemicals, and Material Science being significant contributors.
Industry
Aether operates in the Indian specialty chemicals industry, which is characterized by growing domestic demand and increasing global export opportunities, particularly due to the "China Plus One" strategy. The industry is competitive, with both large established players and numerous smaller firms. Aether positions itself as an R&D-focused, technology-driven manufacturer capable of handling complex and niche chemistry. The company often aims to be the sole or dominant manufacturer for specific advanced intermediates, thereby holding a strong position in its chosen product areas and often catering to global customers with high quality and regulatory compliance needs.
MOAT
R&D and Chemistry Expertise: A strong focus on in-house R&D and process innovation, enabling the development and scaling up of complex, multi-step synthesis products. This leads to a diverse and specialized product portfolio.
Process Efficiency & Cost Competitiveness: Continuous optimization of manufacturing processes to achieve cost efficiencies while maintaining quality.
Customer Stickiness: Due to the specialized nature of its products, long qualification cycles, and critical application in client's value chains, Aether often enjoys long-term relationships with customers.
Diversified Product Portfolio: A wide range of products (over 40 commercialized products) across multiple industries reduces dependence on any single product or sector.
Growth Drivers
"China Plus One" Strategy: Global manufacturers increasingly diversifying their supply chains away from China, benefiting Indian specialty chemical producers like Aether.
Capacity Expansion: Ongoing capital expenditure to debottleneck existing facilities and set up new manufacturing blocks will increase production volumes.
New Product Development: Continuous introduction of new and advanced intermediates and specialty chemicals driven by R&D, expanding addressable markets.
Growing CRAMS Business: Increasing demand for custom synthesis and manufacturing services from global pharmaceutical and agrochemical companies.
Industry Tailwinds: Growing demand from end-user industries like Pharmaceuticals, Agrochemicals, and Material Science, both domestically and internationally.
Risks
Raw Material Price Volatility: Fluctuations in crude oil prices and other key raw material costs can impact profitability.
Environmental & Regulatory Risks: Strict and evolving environmental regulations in the chemical industry necessitate continuous compliance and potential capital expenditure.
Intense Competition: Competition from both domestic and international players in a fragmented market can pressure margins.
Forex Fluctuations: A significant portion of revenue comes from exports, making the company susceptible to adverse currency movements.
Technological Obsolescence: The need to continuously innovate and upgrade processes to remain competitive.
Customer Concentration: While diversified, dependence on a few key customers for specific products could pose a risk if relationships deteriorate.
Management & Ownership
Aether Industries is a promoter-driven company. The management team includes Dr. Aman Desai (Chairman & Managing Director) and Mr. Rohan Desai (Whole-Time Director & CFO), who are part of the promoter family and have strong technical backgrounds and significant experience in the chemical industry. The promoters hold a substantial stake in the company, aligning their interests with long-term growth. The company has a strong focus on R&D and operational excellence, reflecting the technical orientation of its leadership.
Outlook
Aether Industries appears well-positioned to capitalize on the secular growth trends in the global specialty chemicals sector, particularly driven by India's increasing role in the chemical supply chain. Its core strengths in R&D, process innovation, and a diversified product portfolio provide a solid foundation for future growth through planned capacity expansions and new product introductions. However, the company faces inherent risks associated with raw material price volatility, stringent environmental regulations, and intense competition. While demand drivers remain robust, successful execution of its expansion plans and adept management of operational costs will be crucial for sustaining its growth trajectory and profitability.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 155 | 118 | 180 | 199 | 220 | 240 | 256 | 275 | 317 | 305 |
| Other Income | 11 | 12 | 12 | 11 | 14 | 5 | 3 | 9 | 0 | 11 |
| Total Income | 167 | 129 | 192 | 210 | 233 | 245 | 259 | 284 | 317 | 316 |
| Total Expenditure | 124 | 107 | 137 | 145 | 155 | 161 | 175 | 187 | 207 | 222 |
| Operating Profit | 43 | 22 | 55 | 65 | 78 | 85 | 83 | 97 | 111 | 94 |
| Interest | 2 | 4 | 3 | 2 | 3 | 5 | 5 | 3 | 4 | 6 |
| Depreciation | 10 | 10 | 10 | 11 | 11 | 13 | 14 | 17 | 17 | 18 |
| Exceptional Income / Expenses | -6 | -7 | -3 | -3 | -3 | -3 | -3 | -3 | -2 | -1 |
| Profit Before Tax | 24 | 0 | 39 | 49 | 61 | 64 | 62 | 74 | 87 | 68 |
| Provision for Tax | 6 | 2 | 9 | 14 | 18 | 13 | 15 | 20 | 23 | 14 |
| Profit After Tax | 17 | -1 | 30 | 35 | 43 | 50 | 47 | 54 | 64 | 54 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 |
| Profit After Adjustments | 17 | -1 | 30 | 35 | 43 | 50 | 47 | 54 | 64 | 54 |
| Adjusted Earnings Per Share | 1.3 | -0.1 | 2.3 | 2.6 | 3.3 | 3.8 | 3.5 | 4.1 | 4.9 | 4.1 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|
| Net Sales | 590 | 651 | 598 | 839 | 1153 |
| Other Income | 7 | 17 | 39 | 42 | 23 |
| Total Income | 597 | 668 | 637 | 880 | 1176 |
| Total Expenditure | 422 | 465 | 466 | 598 | 791 |
| Operating Profit | 175 | 203 | 171 | 283 | 385 |
| Interest | 13 | 5 | 9 | 13 | 18 |
| Depreciation | 15 | 23 | 40 | 45 | 66 |
| Exceptional Income / Expenses | 0 | 0 | -14 | -12 | -9 |
| Profit Before Tax | 146 | 174 | 110 | 213 | 291 |
| Provision for Tax | 38 | 44 | 27 | 55 | 72 |
| Profit After Tax | 109 | 130 | 82 | 158 | 219 |
| Adjustments | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 109 | 130 | 82 | 158 | 219 |
| Adjusted Earnings Per Share | 9.7 | 10.5 | 6.2 | 11.9 | 16.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 40% | 12% | 0% | 0% |
| Operating Profit CAGR | 65% | 17% | 0% | 0% |
| PAT CAGR | 93% | 13% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 40% | 5% | NA% | NA% |
| ROE Average | 7% | 9% | 14% | 14% |
| ROCE Average | 10% | 12% | 15% | 15% |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Shareholder's Funds | 387 | 1245 | 2063 | 2226 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 122 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 19 | 41 | 48 | 68 |
| Total Current Liabilities | 242 | 94 | 289 | 351 |
| Total Liabilities | 770 | 1380 | 2401 | 2644 |
| Fixed Assets | 257 | 646 | 853 | 1117 |
| Other Non-Current Assets | 103 | 59 | 245 | 389 |
| Total Current Assets | 410 | 675 | 1303 | 1138 |
| Total Assets | 770 | 1380 | 2401 | 2644 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 6 | 18 | 102 | 556 |
| Cash Flow from Operating Activities | -5 | -7 | -16 | 100 |
| Cash Flow from Investing Activities | -151 | -348 | -424 | -418 |
| Cash Flow from Financing Activities | 169 | 439 | 894 | 2 |
| Net Cash Inflow / Outflow | 12 | 84 | 453 | -316 |
| Closing Cash & Cash Equivalent | 18 | 102 | 556 | 240 |
| # | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | 9.67 | 10.47 | 6.22 | 11.95 |
| CEPS(Rs) | 11.04 | 12.34 | 9.22 | 15.34 |
| DPS(Rs) | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 34.28 | 99.83 | 155.31 | 167.38 |
| Core EBITDA Margin(%) | 28.48 | 28.61 | 22.08 | 28.74 |
| EBIT Margin(%) | 27.04 | 27.58 | 19.7 | 26.92 |
| Pre Tax Margin(%) | 24.81 | 26.8 | 18.28 | 25.38 |
| PAT Margin (%) | 18.45 | 20.03 | 13.77 | 18.88 |
| Cash Profit Margin (%) | 21.08 | 23.6 | 20.39 | 24.24 |
| ROA(%) | 14.15 | 12.13 | 4.36 | 6.28 |
| ROE(%) | 28.2 | 16.01 | 5 | 7.41 |
| ROCE(%) | 23.75 | 18.74 | 6.79 | 9.74 |
| Receivable days | 101.09 | 118.42 | 149.84 | 113.43 |
| Inventory Days | 100.63 | 115.35 | 180.42 | 161.02 |
| Payable days | 94.44 | 93.25 | 113.03 | 100.66 |
| PER(x) | 0 | 89.52 | 125.44 | 69.53 |
| Price/Book(x) | 0 | 9.39 | 5.03 | 4.96 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.64 | 17.77 | 16.65 | 13.06 |
| EV/Core EBITDA(x) | 2.17 | 57.06 | 58.09 | 38.74 |
| Net Sales Growth(%) | 0 | 10.34 | -8.13 | 40.21 |
| EBIT Growth(%) | 0 | 12.51 | -34.27 | 91.41 |
| PAT Growth(%) | 0 | 19.72 | -36.75 | 92.05 |
| EPS Growth(%) | 0 | 8.36 | -40.58 | 91.99 |
| Debt/Equity(x) | 0.74 | 0 | 0.08 | 0.08 |
| Current Ratio(x) | 1.69 | 7.18 | 4.51 | 3.25 |
| Quick Ratio(x) | 1.02 | 4.54 | 3.32 | 2.11 |
| Interest Cover(x) | 12.16 | 35.26 | 13.86 | 17.47 |
| Total Debt/Mcap(x) | 0 | 0 | 0.02 | 0.02 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 81.79 | 81.79 | 81.79 | 81.79 | 81.77 | 81.77 | 75 | 75 | 74.98 | 74.95 |
| FII | 1.98 | 2.22 | 2.9 | 3.17 | 3.33 | 3.34 | 5.04 | 4.64 | 5.81 | 6.29 |
| DII | 11.8 | 11.82 | 11.56 | 11.63 | 11.49 | 11.43 | 13.41 | 12.97 | 12.25 | 12.66 |
| Public | 4.43 | 4.17 | 3.75 | 3.41 | 3.41 | 3.46 | 6.56 | 7.39 | 6.96 | 6.11 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 10.84 | 10.84 | 10.84 | 10.84 | 10.84 | 10.84 | 9.94 | 9.94 | 9.94 | 9.94 |
| FII | 0.26 | 0.29 | 0.38 | 0.42 | 0.44 | 0.44 | 0.67 | 0.61 | 0.77 | 0.83 |
| DII | 1.56 | 1.57 | 1.53 | 1.54 | 1.52 | 1.52 | 1.78 | 1.72 | 1.62 | 1.68 |
| Public | 0.59 | 0.55 | 0.5 | 0.45 | 0.45 | 0.46 | 0.87 | 0.98 | 0.92 | 0.81 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13.26 | 13.26 | 13.26 | 13.26 | 13.26 | 13.26 | 13.26 | 13.26 | 13.26 | 13.27 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +40% | +12% | — | — |
| Operating Profit CAGR | +65% | +17% | — | — |
| PAT CAGR | +93% | +13% | — | — |
| Share Price CAGR | +40% | +5% | — | — |
| ROE Average | +7% | +9% | +14% | +14% |
| ROCE Average | +10% | +12% | +15% | +15% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 81.79 | 81.79 | 81.79 | 81.79 | 81.77 | 81.77 | 75 | 75 | 74.98 | 74.95 |
| FII | 1.98 | 2.22 | 2.9 | 3.17 | 3.33 | 3.34 | 5.04 | 4.64 | 5.81 | 6.29 |
| DII | 11.8 | 11.82 | 11.56 | 11.63 | 11.49 | 11.43 | 13.41 | 12.97 | 12.25 | 12.66 |
| Public | 18.21 | 18.21 | 18.21 | 18.21 | 18.23 | 18.23 | 25 | 25 | 25.02 | 25.05 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 10.84 | 10.84 | 10.84 | 10.84 | 10.84 | 10.84 | 9.94 | 9.94 | 9.94 | 9.94 |
| FII | 0.26 | 0.29 | 0.38 | 0.42 | 0.44 | 0.44 | 0.67 | 0.61 | 0.77 | 0.83 |
| DII | 1.56 | 1.57 | 1.53 | 1.54 | 1.52 | 1.52 | 1.78 | 1.72 | 1.62 | 1.68 |
| Public | 2.41 | 2.41 | 2.41 | 2.41 | 2.42 | 2.42 | 3.32 | 3.32 | 3.32 | 3.32 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13.26 | 13.26 | 13.26 | 13.26 | 13.26 | 13.26 | 13.26 | 13.26 | 13.26 | 13.27 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.